Speaker(s): 

Teresa Baker, MD, FACOG, Outside Speaker, Texas Tech University - has nothing to disclose. 

Moderator(s): 

Dr. Keith Williams, MD, Staff member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Describe difference between phytocannabinoids and endocannabinoids

  • Describe potential role of endocannabinoids in human milk

  • Describe factors that may influence the level of endocannabinoids in human milk

  • To understand factors associated with frequent cannabis use in breastfeeding mothers

  • To describe the transfer of Δ9-THC and its metabolites into human milk at 20 min, 1, 2 and 4 hours after maternal inhalation of 0.1 g cannabis containing 23.18% of Δ9-THC

  • To discuss ethical issues regarding cannabis and breastfeeding

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Jay Bringman, MD, Sandra Culbertson, MD, Brittany Meyer, PA-C, Michelle Bafile, PA-C, Lindsay Payne, Stephanie Worhach, RN, Keith Williams, MD, and Orlando Valle, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Michaelyn Notz, DO, Timothy Murphy, MD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
12/04/2025 - 8:15am to 9:15am EST
Location: 
Geisinger Medical Center Beecham Library-Women's Health
Danville, PA 17822
United States
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.